- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00156234
Skeletal Muscle Dysfunction in Heart Failure
September 8, 2005 updated by: Ullevaal University Hospital
Training and Congestive Heart Failure
Patients suffering from congestive heart failure report reduced exercise capacity. This skeletal muscle dysfunction is also detectable when using small muscle groups which should not put any demand on the heart.
We hypothesize that congestive heart failure has systemic effects that causes the skeletal muscle dysfunction.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oslo, Norway, 0806
- Recruiting
- Norwegian School of Sport Sciences
-
Contact:
- Jostein Hallén, Professor
- Phone Number: 47 23 26 23 14
- Email: jostein.hallen@nih.no
-
Contact:
- Gunnar Petersen, Ph.D student
- Email: gunnar.petersen@nih.no
-
Sub-Investigator:
- Jostein Hallen, Professor
-
Oslo, Norway, 0407
- Recruiting
- Institute for Experimental Medical Research
-
Contact:
- Ole M Sejersted, Professor
- Phone Number: 47 23 01 68 00
- Email: o.m.sejersted@medisin.uio.no
-
Contact:
- Per Kristian B Lunde, Post Doc
- Phone Number: 47 23 01 68 35
- Email: p.k.lunde@medisin.uio.no
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 78 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Coronary Heart Failure
- Ejection fraction <35%
- NYHA 2-3
- Spirometry FEV1 > 80%
Exclusion Criteria:
- Cardiomyopathy
- Transplantation candidate
- Active malignancy
- Restraining skeletal-muscular disease
- Claudication in legs
- Hospitalized last 30 days due to acute ischemic episode
- Intravenous inotrope or vasodilatating drugs last 14 days prior to inclusion
- AMI last 8 weeks prior to inclusion
- Organized training last 4 months
- Smoking on daily basis last 4 months
- Creatinin < 150microliters/liter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: ECT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Ole M Sejersted, Professor, Institute for Experimental Medical Research, Ullevaal University Hospital
- Study Director: Per Kristian B Lunde, Post Doc, Institute for Experimental Medical Research, Ullevaal University Hospital
- Study Director: Ivar Sjaastad, Post Doc, Institute for Experimental Medical Research, Ullevaal University Hospital
- Study Chair: Jostein Hallen, Professor, Norwegian School of Sport Sciences
- Principal Investigator: Morten Munkvik, Ph.D student, Institute for Experimental Medical Research, Ullevaal University Hospital
- Principal Investigator: Tommy A Rehn, Vit.ass., Institute for Experimental Medical Research, Ullevaal University Hospital
- Principal Investigator: Gunnar S Petersen, Ph.D student, Norwegian School of Sport Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2005
Study Registration Dates
First Submitted
September 8, 2005
First Submitted That Met QC Criteria
September 8, 2005
First Posted (ESTIMATE)
September 12, 2005
Study Record Updates
Last Update Posted (ESTIMATE)
September 12, 2005
Last Update Submitted That Met QC Criteria
September 8, 2005
Last Verified
September 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRUST-001
- Helse Øst
- Helse og rehabilitering
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.